Antithrombotic drugs in acutely ill medical patients: review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux

By Loffredo Lorenzo   Perri Ludovica   Catasca Elisa   Del Ben Maria   Angelico Francesco   Violi Francesco  

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 615-627

Future Medicine

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin versus Unfractionated Heparin in the Treatment of Patients with Acute Pulmonary Thromboembolism

By  

Respiration, Vol. 69, Iss. 5, 2002-09 ,pp. : 440-444

Karger

Access to resources Recommend Favorite

Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 35-42

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 4, 2004-12 ,pp. : 197-201

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparins in Acute Unstable Coronary Artery Disease – An Update

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 72-75

Karger

Access to resources Recommend Favorite